Insider Buying: Quantum-Si (NASDAQ:QSI) Director Acquires $104,395.50 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) Director Paula Dowdy bought 109,890 shares of the company’s stock in a transaction on Thursday, March 5th. The stock was purchased at an average price of $0.95 per share, with a total value of $104,395.50. Following the completion of the transaction, the director directly owned 269,107 shares of the company’s stock, valued at approximately $255,651.65. The trade was a 69.02% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Quantum-Si Trading Up 1.0%

Shares of QSI stock opened at $1.05 on Thursday. The firm has a market capitalization of $226.26 million, a price-to-earnings ratio of -2.02 and a beta of 3.00. The business’s 50-day moving average price is $1.09 and its 200-day moving average price is $1.37. Quantum-Si Incorporated has a 12 month low of $0.84 and a 12 month high of $3.10.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The company had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. On average, sell-side analysts predict that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on QSI. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Canaccord Genuity Group decreased their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 4th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Quantum-Si currently has a consensus rating of “Hold” and a consensus target price of $3.25.

Institutional Trading of Quantum-Si

A number of institutional investors and hedge funds have recently added to or reduced their stakes in QSI. Prudential Financial Inc. bought a new position in Quantum-Si during the 2nd quarter worth approximately $25,000. Curbstone Financial Management Corp acquired a new stake in shares of Quantum-Si during the fourth quarter worth $26,000. Capital Investment Advisory Services LLC increased its position in shares of Quantum-Si by 100.0% during the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after buying an additional 10,000 shares during the period. Leonteq Securities AG bought a new position in Quantum-Si during the fourth quarter worth $28,000. Finally, Elite Life Management LLC bought a new position in Quantum-Si during the third quarter worth $29,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.